Related Experiment Video
Updated: Jul 22, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
A Case of Advanced Breast Cancer Successfully Treated with Primary Endocrine Therapy
1Department of Surgery, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Primary endocrine therapy, including ovarian ablation and combined hormonal agents, shows promise for advanced hormone-sensitive breast cancer. This approach led to a favorable outcome and quality of life in a premenopausal patient.
Area of Science:
- Oncology
- Endocrinology
Background:
- Advanced hormone-sensitive breast cancer requires effective treatment strategies.
- Primary endocrine therapy is an emerging option for managing this condition.
Purpose of the Study:
- To present a case study of a premenopausal woman with advanced hormone-sensitive breast cancer treated with primary endocrine therapy.
- To evaluate the efficacy and tolerability of this treatment approach.
Main Methods:
- Ovarian ablation followed by a combined regimen of fadrozole (aromatase inhibitor) and tamoxifen.
- Progressive ratio (PR) evaluation of loco-regional lesions during treatment.
- Mastectomy with axillary lymph node dissection post-initial therapy.
Main Results:
- Successful treatment of advanced hormone-sensitive breast cancer.
- No adverse events reported during the treatment course.
- Favorable quality of life maintained by the patient.
Conclusions:
- Primary endocrine therapy is a promising treatment option for hormone-sensitive breast cancer.
- This case highlights the potential of combined endocrine therapy in advanced disease.
- Further research is needed as this modality is still considered experimental.
More Related Videos
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers